StockNews.com Initiates Coverage on Mirati Therapeutics (NAS

StockNews.com began coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a research note released on Tuesday. The brokerage issued a sell rating on the biotechnology company’s stock. Several other analysts have also recently commented on MRTX. Piper Sandler cut shares of Mirati Therapeutics from an overweight rating to a neutral rating and […]

Related Keywords

United States , Jamie Christensen , Benjamin Hickey , Leerink Partnrs , Piper Sandler , Scotiabank , Us Bancorp , Mirati Therapeutics Inc , Blackrock Inc , Securities Exchange Commission , Acadian Asset Management , Advisor Group Holdings Inc , Mirati Therapeutics Company Profile , Metlife Investment Management , Mirati Therapeutics , Free Report , Therapeutics Trading Down , Get Free Report , Exchange Commission , Group Holdings , Asset Management , Life Investment Management , Mirati Therapeutics Daily , Nasdaq Mrtx , Mrtx , Medical , Initiated Coverage , Stocknews Com ,